Coeur to Present at Gold Forum Americas

Coeur Mining (NYSE: CDE) has announced its participation in the Gold Forum Americas, an exclusive investment conference.

(Neutral)

Rhea-AI Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Tags

conferences

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

09/10/2024 - 04:30 PM

CHICAGO--(BUSINESS WIRE)-- Coeur Mining, Inc.’s (“Coeur” or the “Company”) (NYSE: CDE) Chairman, President and Chief Executive Officer, Mitchell J. Krebs, will present at Gold Forum Americas in Colorado Springs, Colorado on Monday, September 16, 2024 at 9:10 a.m. Mountain Time.

The Gold Forum Americas is an invitation-only investment conference. Presentation materials will be made available on the Company’s website at www.coeur.com.

About Coeur

Coeur Mining, Inc. is a U.S.-based, well-diversified, growing precious metals producer with four wholly-owned operations: the Palmarejo gold-silver complex in Mexico, the Rochester silver-gold mine in Nevada, the Kensington gold mine in Alaska and the Wharf gold mine in South Dakota. In addition, the Company wholly-owns the Silvertip polymetallic critical minerals exploration project in British Columbia.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240910327302/en/

Coeur Mining, Inc.
Jeff Wilhoit, Senior Director, Investor Relations
(312) 489-5800
www.coeur.com

Source: Coeur Mining

Keep reading

More on CDE

Sep 22, 2026 Coeur Provides Exploration Update for New Afton and Rainy River
Sep 21, 2026 Coeur to Present at Mining Forum Americas
Aug 5, 2026 Coeur Reports Second Quarter 2026 Results

All CDE news

Trending in the feed

ARGX

argenx Provides Update on Phase 3 UNITY Study of Efgartigimod SC in Sjögren's Disease Open the live feed